We have observed
11 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after February 23, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
METHOD FOR DETECTION OF PREDISPOSITION TO ATHEROSCLEROSIS, CORONARY HEART DISEASE AND RELATED CONDITIONS
NEUROPROTECTIVE CELL-PENETRATING PEPTIDES
METHOD AND PRIMERS FOR THE DETECTION OF MICROCYSTIN-PRODUCING TOXIC CYANOBACTERIA
A TRANSGENIC ANIMAL COMPRISING A DELETION OR FUNCTIONAL DELETION OF THE 3'UTR OF AN ENDOGENOUS GENE.
METHOD FOR MEASURING RADIOACTIVITY
METHOD FOR COMPETITIVE ALLELE-SPECIFIC CDNA SYNTHESIS AND DIFFERENTIAL AMPLIFICATION OF THE CDNA PRODUCTS
METHOD FOR PRODUCING HYPERACTIVE TRANSPOSASE MUTANTS
METHOD FOR DETERMINING THE PRESENCE OF DIARRHOEA CAUSING PATHOGENS
SULPHATED HYALURONIC ACID IN COMBINATION WITH G-CSF FOR USE IN MOBILISING BLOOD STEM CELLS
METHOD FOR DETECTING HELICOBACTER PYLORI DNA IN A STOOL SAMPLE
METHOD FOR PREPARING PEPTIDE INHIBITORS OF A LIPID-ACTIVATED ENZYME AND PEPTIDES PRODUCED BY SAME